ES2188992T3 - Gen del crecimiento humano y region del gen de baja estatura. - Google Patents
Gen del crecimiento humano y region del gen de baja estatura.Info
- Publication number
- ES2188992T3 ES2188992T3 ES97944906T ES97944906T ES2188992T3 ES 2188992 T3 ES2188992 T3 ES 2188992T3 ES 97944906 T ES97944906 T ES 97944906T ES 97944906 T ES97944906 T ES 97944906T ES 2188992 T3 ES2188992 T3 ES 2188992T3
- Authority
- ES
- Spain
- Prior art keywords
- gene
- man
- phenotype
- stature
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 102000009331 Homeodomain Proteins Human genes 0.000 abstract 1
- 108010048671 Homeodomain Proteins Proteins 0.000 abstract 1
- 208000020221 Short stature Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA MOLECULA AISLADA DE ACIDO NUCLEICO DEL HOMBRE QUE CODIFICA UNOS POLIPEPTIDOS QUE CONTIENEN UN DOMINIO DE CAJA HOMEOTICA DE SESENTA ACIDOS AMINADOS QUE PRESENTAN LA SECUENCIA DE ACIDOS AMINADOS DE SEQ ID NO: 1 Y QUE EJERCEN UNA ACTIVIDAD DE REGULACION DEL CRECIMIENTO EN EL HOMBRE. SE HAN IDENTIFICADO TRES NUEVOS GENES QUE RESIDEN EN LA ZONA CRITICA DE LA INSUFICIENCIA ESTATURAL DE APROXIMADAMENTE 500 KB SOBRE EL CROMOSOMA X E Y. POR LO MENOS UNO DE ESTOS GENES ES RESPONSABLE DEL FENOTIPO DE LA ESTATURA CORTA. EL ADNC QUE CORRESPONDE A ESTE GEN SE PUEDE USAR EN INSTRUMENTOS DIAGNOSTICOS, PARA CARACTERIZAR LUEGO LA BASE MOLECULAR DEL FENOTIPO DE PEQUEÑA ESTATURA. ADEMAS, LA IDENTIFICACION DEL PRODUCTO GENICO DEL GEN PROPORCIONA NUEVOS MEDIOS Y PROCEDIMIENTOS PARA EL DESARROLLO DE TERAPIAS SUPERIORES PARA LA ESTATURA CORTA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2763396P | 1996-10-01 | 1996-10-01 | |
| EP97100583 | 1997-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2188992T3 true ES2188992T3 (es) | 2003-07-01 |
Family
ID=26145174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97944906T Expired - Lifetime ES2188992T3 (es) | 1996-10-01 | 1997-09-29 | Gen del crecimiento humano y region del gen de baja estatura. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7252974B2 (es) |
| EP (2) | EP1260228A3 (es) |
| JP (2) | JP2000515025A (es) |
| KR (1) | KR20000048838A (es) |
| CN (1) | CN1232499A (es) |
| AT (1) | ATE230026T1 (es) |
| AU (1) | AU744188C (es) |
| BR (1) | BR9712185A (es) |
| CA (2) | CA2647169A1 (es) |
| CZ (1) | CZ297640B6 (es) |
| DE (1) | DE69718052T2 (es) |
| DK (1) | DK0946721T3 (es) |
| ES (1) | ES2188992T3 (es) |
| HU (1) | HU225131B1 (es) |
| IL (1) | IL129015A0 (es) |
| NO (1) | NO991554L (es) |
| NZ (1) | NZ334970A (es) |
| PL (1) | PL194248B1 (es) |
| SI (1) | SI0946721T1 (es) |
| WO (1) | WO1998014568A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4011100A (en) * | 1999-03-19 | 2000-10-09 | Human Genome Sciences, Inc. | 48 human secreted proteins |
| CA2368469A1 (en) * | 1999-03-26 | 2000-10-05 | Craig A. Rosen | 50 human secreted proteins |
| US7736654B2 (en) | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
| US20040248132A1 (en) | 2001-10-04 | 2004-12-09 | Toshiyuki Sakai | DR5 gene promoter and siah-1 gene promoter |
| US20060172929A1 (en) * | 2003-01-13 | 2006-08-03 | Gudrun Rappold-Hoerbrand | Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| CN114921544A (zh) | 2005-04-15 | 2022-08-19 | Epi基因组股份公司 | 分析细胞增殖性病症的方法和核酸 |
| US7382944B1 (en) | 2006-07-14 | 2008-06-03 | The United States Of America As Represented By The Administration Of The National Aeronautics And Space Administration | Protective coating and hyperthermal atomic oxygen texturing of optical fibers used for blood glucose monitoring |
| SI2258871T1 (sl) * | 2007-01-19 | 2014-09-30 | Epigenomics Ag Intellectual Property | Postopki in nukleinske kisline za analize celičnih proliferativnih motenj |
| EP2994541A4 (en) * | 2013-05-06 | 2017-01-18 | Capilet Genetics AB | Diagnostic test for skeletal atavism in horses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445933A1 (de) * | 1984-12-17 | 1986-06-19 | Röhm GmbH, 6100 Darmstadt | Arzneimittel mit diuretischer wirksamkeit |
| US4983511A (en) * | 1989-01-09 | 1991-01-08 | Olin Corporation | Method and kit for detecting live microorganisms in chlorine- or bromine-treated water |
-
1997
- 1997-09-29 ES ES97944906T patent/ES2188992T3/es not_active Expired - Lifetime
- 1997-09-29 DK DK97944906T patent/DK0946721T3/da active
- 1997-09-29 DE DE69718052T patent/DE69718052T2/de not_active Expired - Lifetime
- 1997-09-29 HU HU9904175A patent/HU225131B1/hu not_active IP Right Cessation
- 1997-09-29 EP EP02011329A patent/EP1260228A3/en not_active Withdrawn
- 1997-09-29 KR KR1019990702836A patent/KR20000048838A/ko not_active Withdrawn
- 1997-09-29 BR BR9712185-1A patent/BR9712185A/pt unknown
- 1997-09-29 CZ CZ0096699A patent/CZ297640B6/cs not_active IP Right Cessation
- 1997-09-29 CA CA002647169A patent/CA2647169A1/en not_active Abandoned
- 1997-09-29 AU AU46252/97A patent/AU744188C/en not_active Ceased
- 1997-09-29 IL IL12901597A patent/IL129015A0/xx unknown
- 1997-09-29 WO PCT/EP1997/005355 patent/WO1998014568A1/en not_active Ceased
- 1997-09-29 JP JP10516222A patent/JP2000515025A/ja active Pending
- 1997-09-29 SI SI9730485T patent/SI0946721T1/xx unknown
- 1997-09-29 PL PL97332568A patent/PL194248B1/pl not_active IP Right Cessation
- 1997-09-29 NZ NZ334970A patent/NZ334970A/xx unknown
- 1997-09-29 AT AT97944906T patent/ATE230026T1/de active
- 1997-09-29 CA CA002267097A patent/CA2267097A1/en not_active Abandoned
- 1997-09-29 EP EP97944906A patent/EP0946721B1/en not_active Expired - Lifetime
- 1997-09-29 CN CN97198471A patent/CN1232499A/zh active Pending
-
1999
- 1999-03-30 NO NO991554A patent/NO991554L/no not_active Application Discontinuation
-
2002
- 2002-05-31 US US10/158,160 patent/US7252974B2/en not_active Expired - Fee Related
-
2004
- 2004-03-02 JP JP2004058276A patent/JP2004201692A/ja active Pending
-
2007
- 2007-05-15 US US11/748,769 patent/US20090111744A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE230026T1 (de) | 2003-01-15 |
| JP2004201692A (ja) | 2004-07-22 |
| CN1232499A (zh) | 1999-10-20 |
| SI0946721T1 (en) | 2003-06-30 |
| US20030059805A1 (en) | 2003-03-27 |
| AU4625297A (en) | 1998-04-24 |
| CZ297640B6 (cs) | 2007-02-21 |
| NO991554L (no) | 1999-05-14 |
| HU225131B1 (en) | 2006-06-28 |
| EP0946721B1 (en) | 2002-12-18 |
| PL194248B1 (pl) | 2007-05-31 |
| US7252974B2 (en) | 2007-08-07 |
| PL332568A1 (en) | 1999-09-27 |
| AU744188C (en) | 2003-07-24 |
| BR9712185A (pt) | 1999-08-31 |
| DE69718052T2 (de) | 2003-07-31 |
| DK0946721T3 (da) | 2003-04-14 |
| US20090111744A1 (en) | 2009-04-30 |
| DE69718052D1 (de) | 2003-01-30 |
| HUP9904175A2 (hu) | 2000-04-28 |
| HUP9904175A3 (en) | 2002-01-28 |
| IL129015A0 (en) | 2000-02-17 |
| EP0946721A1 (en) | 1999-10-06 |
| EP1260228A2 (en) | 2002-11-27 |
| AU744188B2 (en) | 2002-02-14 |
| CA2267097A1 (en) | 1998-04-09 |
| KR20000048838A (ko) | 2000-07-25 |
| EP1260228A3 (en) | 2003-03-05 |
| WO1998014568A1 (en) | 1998-04-09 |
| CA2647169A1 (en) | 1998-04-09 |
| NZ334970A (en) | 2000-12-22 |
| CZ96699A3 (cs) | 1999-08-11 |
| JP2000515025A (ja) | 2000-11-14 |
| NO991554D0 (no) | 1999-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2188992T3 (es) | Gen del crecimiento humano y region del gen de baja estatura. | |
| Senger et al. | Microdissection of banded human chromosomes | |
| Shaffer et al. | Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme. | |
| Altshuller et al. | Gcm1, a mammalian homolog of Drosophila glial cells missing | |
| Pickard et al. | Epigenetic targeting in the mouse zygote marks DNA for later methylation: a mechanism for maternal effects in development | |
| Leonhardt et al. | Structure, function and regulation of mammalian DNA methyltransferase | |
| Hatada et al. | Identification of a new imprinted gene, Rian, on mouse chromosome 12 by fluorescent differential display screening | |
| Wilcox et al. | Comparative mapping identifies the fusion point of an ancient mammalian X-autosomal rearrangement | |
| Ciavatta et al. | A DNA insulator prevents repression of a targeted X-linked transgene but not its random or imprinted X inactivation | |
| Hirai et al. | FISH techniques for constructing physical maps on schistosome chromosomes | |
| Artero et al. | Saliva, a new Drosophila gene expressed in the embryonic salivary glands with homologues in plants and vertebrates | |
| Yi et al. | Bcl‐rambo beta, a special splicing variant with an insertion of an Alu‐like cassette, promotes etoposide‐and Taxol‐induced cell death | |
| Brown et al. | Beyond sense: the role of antisense RNA in controlling Xist expression | |
| Fischel-Ghodsian et al. | Long range genome structure around the human α-globin complex analysed by PFGE | |
| Beinert et al. | Systematic gene targeting on the X chromosome of Drosophila melanogaster | |
| Redeker et al. | Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15. 3 | |
| Kraemer et al. | The new gene DmX from Drosophila melanogaster encodes a novel WD-repeat protein | |
| Mullan et al. | Uncovering BRCAI-regulated signalling pathways by microarray-based expression profiling | |
| ATE348893T1 (de) | Tgc-verfahren zur induktion einer zielgerichteten,somatischen transgenität | |
| Tsipouras et al. | Genetic distance of two fibrillar collagen loci, COL3A1 and COL5A2, located on the long arm of human chromosome 2 | |
| Baron et al. | GNAI3, GNAT2, AMPD2, GSTM are clustered in 120 kb of Chinese hamster chromosome 1q | |
| Dixon et al. | Assignment of human B2-1 gene (D17S811E) to chromosome 17qter by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization | |
| DE69225797D1 (de) | Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x | |
| AU1671199A (en) | Nucleic acids involved in the responder phenotype and applications thereo | |
| Harte | Response of the corresponding author |